Stock markets LIVE: S&P 500, Dow Jones and Nasdaq futures sink hours after Trump bombshell | Personal Finance | Finance

6 days ago


An MP has written to the UK and Scottish health secretaries about concerns that Donald Trump‘s tariffs could impact medicine supplies across Britain.

Scottish Liberal Democrat deputy leader Wendy Chamberlain warned of “life-threatening” consequences if the measures from the US Government impact the availability of medication in the UK.

Her letters come after UK Health Secretary Wes Streeting warned tariffs on medication would be “another layer of challenge” for an industry already facing issues with manufacturing and distribution.

Ms Chamberlain said: “We have already seen the impact that months of ADHD medication shortages caused, many of my constituents experienced inconsistent treatment or outright refusal of treatment as a result of the shortages. If the tariffs impact medication supplies even more widely, it will undoubtedly lead to many more people experiencing inadequate treatment.

“This is simply unacceptable and could be life-threatening. I urge both governments to do all they can to ensure that people across the UK do not suffer as a result of Trump’s tariffs.”

Mr Trump has placed a minimum 10% universal tariff on all countries except China, which now faces tariffs of 125%. Another 25% levy is also in place for all aluminium, steel and cars entering the US.

Pharmaceuticals and cars are some of the biggest trading sectors between the US and the UK.

Speaking earlier this week, Mr Streeting warned tariffs would compound issues already facing the pharmaceutical industry.

He said: “Until this trade war erupted, we’d already had issues with medicines production and supply internationally. We are constantly watching and acting on this situation to try and get medicines into the country, to make sure we’ve got availability, to show some flexibility in terms of how medicines are dispensed, to deal with shortages.

Keep exploring EU Venture Capital:  Natural Gas and Oil Forecast: Demand Uncertainty and Supply Risks Drive Market Instability

“But whether it’s medicines, whether it’s parts for manufacturing, whether it’s… the ability of businesses in this country to turn a profit, this is an extremely turbulent situation.”

However, he appeared to reassure: “We watch this situation extremely closely. We work on a daily basis to make sure that we have the medicine supply this country needs.”



Source link

EU Venture Capital

EU Venture Capital is a premier platform providing in-depth insights, funding opportunities, and market analysis for the European startup ecosystem. Wholly owned by EU Startup News, it connects entrepreneurs, investors, and industry professionals with the latest trends, expert resources, and exclusive reports in venture capital.

Leave a Reply

Your email address will not be published.